MN
Monopar Therapeutics Inc.
MNPR · NASDAQ
$96.47 -7.20% (-$7.49)
1M -13.37%
Market Cap $688.0M
P/E Ratio -
Div. Yield -
ROE 13.08%
Bulios Fair Price
$64.1
33.6% downside
Trenutna cena
$96.47
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MNPR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
0/9Valuation
34 /100
Fair P/B 5.26x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 139.05%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 16.89%
ROE 13.08%
ROA 13.22%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 33.56x
Int. coverage N/A
Stability
13 /100
Unstable Beta 1.50x
EPS volatility 82.83%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MNPR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chandler D. Robinson
Employees
22
Headquarters
Wilmette
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report